CellCentric raised £27.2M with RA Capital Management
19 July 2024
19 July 2024
Total investments received (USD): 154.98m
Round value (USD): 34.98m
Round investors:
RA Capital Management
Company: CellCentric
Related deals
bit.bio raised $30 million post series B led by M&G Investments, joined by ARCH Venture Partners, BlueYard Capital, Milky Way, Puhua Capital, and Tencent
Investments
21 December 2024
Epitopea raised $31M in a pre-series A funding round with Investissement Québec, adMare BioInnovations, Jonathan Milner and existing investors
Investments
15 October 2024
Aviado Bio in a $20M strategic equity deal with Astellas Pharma
Investments
02 October 2024
LoQus23 raised £35M series A led by Forbion Partners, joined by SV Health Investors, Novartis Venture Fund and Dementia Discovery Fund
Investments
03 September 2024
Enara Bio raised $32.5m in Series B funding co-led by Pfizer Ventures and M Ventures, joined by RA Capital, Samsara BioCapital, and SV Health Investors.
Investments
03 September 2024
Belgium
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain